1374 related articles for article (PubMed ID: 31587602)
21. Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction.
Martens P; Nijst P; Verbrugge FH; Smeets K; Dupont M; Mullens W
Acta Cardiol; 2018 Apr; 73(2):115-123. PubMed ID: 28730869
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum.
Savarese G; Jonsson Å; Hallberg AC; Dahlström U; Edner M; Lund LH
Int J Cardiol; 2020 Jan; 298():59-65. PubMed ID: 31521440
[TBL] [Abstract][Full Text] [Related]
23. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
Sartipy U; Dahlström U; Fu M; Lund LH
JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
[TBL] [Abstract][Full Text] [Related]
25. Mild and moderate to severe early acute kidney injury following cardiac surgery among patients with heart failure and preserved vs. mid-range vs. reduced ejection fraction: A retrospective cohort study.
Gao Y; Wang C; Li J; Ji B; Wang J; Yan F; Wang Y
Eur J Anaesthesiol; 2022 Aug; 39(8):673-684. PubMed ID: 35791895
[TBL] [Abstract][Full Text] [Related]
26. Different relationships between pulse pressure and mortality in heart failure with reduced, mid-range and preserved ejection fraction.
Teng TK; Tay WT; Dahlstrom U; Benson L; Lam CSP; Lund LH
Int J Cardiol; 2018 Mar; 254():203-209. PubMed ID: 29407092
[TBL] [Abstract][Full Text] [Related]
27. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
[TBL] [Abstract][Full Text] [Related]
28. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
[TBL] [Abstract][Full Text] [Related]
29. Current conditions and significance of outpatient cardiac rehabilitation and home nursing-care services in heart failure patients with mid-range or preserved ejection fraction: post-hoc analysis of the REAL-HF registry.
Kitagawa T; Hidaka T; Watanabe N; Naka M; Yamaguchi M; Kanai K; Isobe M; Kihara Y; Nakano Y;
Heart Vessels; 2022 May; 37(5):745-754. PubMed ID: 34731295
[TBL] [Abstract][Full Text] [Related]
30. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.
Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G
JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
Heart; 2018 Mar; 104(6):525-532. PubMed ID: 28982721
[TBL] [Abstract][Full Text] [Related]
32. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
[TBL] [Abstract][Full Text] [Related]
33. Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry.
Agra Bermejo R; Gonzalez Babarro E; López Canoa JN; Varela Román A; Gómez Otero I; Oro Ayude M; Parada Vazquez P; Gómez Rodríguez I; Díaz Castro O; González Juanatey JR
Cardiol J; 2018; 25(3):353-362. PubMed ID: 28980289
[TBL] [Abstract][Full Text] [Related]
34. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y
Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
[TBL] [Abstract][Full Text] [Related]
35. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
[TBL] [Abstract][Full Text] [Related]
36. Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study.
Lam CSP; Gamble GD; Ling LH; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Cameron VA; Poppe K; Lund M; Devlin G; Troughton R; Richards AM; Doughty RN
Eur Heart J; 2018 May; 39(20):1770-1780. PubMed ID: 29390051
[TBL] [Abstract][Full Text] [Related]
37. Mode of Death Among Japanese Adults With Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
Kitai T; Miyakoshi C; Morimoto T; Yaku H; Murai R; Kaji S; Furukawa Y; Inuzuka Y; Nagao K; Tamaki Y; Yamamoto E; Ozasa N; Tang WHW; Kato T; Kimura T
JAMA Netw Open; 2020 May; 3(5):e204296. PubMed ID: 32379331
[TBL] [Abstract][Full Text] [Related]
38. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
[TBL] [Abstract][Full Text] [Related]
39. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease.
Fu EL; Uijl A; Dekker FW; Lund LH; Savarese G; Carrero JJ
Circ Heart Fail; 2020 Nov; 13(11):e007180. PubMed ID: 33070637
[TBL] [Abstract][Full Text] [Related]
40. Characteristics and long-term prognosis of patients with heart failure and mid-range ejection fraction compared with reduced and preserved ejection fraction: a systematic review and meta-analysis.
Lauritsen J; Gustafsson F; Abdulla J
ESC Heart Fail; 2018 Aug; 5(4):685-694. PubMed ID: 29660263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]